Skip to main content
Cardiolucent

Treatment

Anticoagulation Management

Therapies

Anticoagulation therapy prevents stroke and thromboembolic events in patients with atrial fibrillation, mechanical heart valves, prior deep vein thrombosis or pulmonary embolism, and selected hypercoagulable conditions. The challenge is that the same medications that prevent clots can also cause bleeding, so the program is fundamentally about ongoing risk balancing rather than a single prescribing decision. Dr. Kedan provides comprehensive anticoagulation management at Cardiolucent — agent selection, periprocedural planning, monitoring, and direct access when bleeding concerns or scheduled procedures arise. This overview frames the program; specific drug-class detail (warfarin vs DOACs, dosing, monitoring intervals) is covered in the dedicated treatments page on warfarin and DOACs.

What This Treatment Approach Includes

  • Stroke and bleeding risk quantification with CHA2DS2-VASc and HAS-BLED scoring
  • Agent selection individualized to anatomy, kidney function, other medications, and lifestyle
  • Initiation, dose adjustment, and renal-function-based dose modification over time
  • Periprocedural anticoagulation planning, including bridging when warranted
  • Routine labs: INR for warfarin, plus kidney function, liver function, and CBC for DOACs
  • Drug-interaction and supplement review at every visit
  • Patient education on bleeding warning signs and adherence

How It Works

Anticoagulants interrupt the coagulation cascade at different points — warfarin inhibits vitamin K–dependent clotting factors, direct oral anticoagulants block specific factors (Xa or thrombin) selectively — reducing the body's ability to form pathologic clots in the heart and venous circulation. The goal is enough anticoagulation to prevent stroke or recurrent thromboembolism, but not so much that everyday bleeding becomes dangerous. Continuous reassessment keeps the regimen calibrated as kidney function, comorbidities, and other medications change.

Who This Is For

  • Atrial fibrillation with elevated stroke risk (CHA2DS2-VASc ≥ 2 in men, ≥ 3 in women)
  • Mechanical heart valves requiring lifelong anticoagulation
  • Prior deep vein thrombosis or pulmonary embolism, including unprovoked recurrences
  • Inherited or acquired hypercoagulable disorders
  • Left ventricular thrombus or selected cardiomyopathies with thrombus risk
  • Patients requiring periprocedural anticoagulation coordination
  • Anyone seeking expert ongoing oversight of an established anticoagulation regimen

Monitoring and Follow-Up

Warfarin requires regular INR checks to keep the dose in the therapeutic range; DOACs do not require routine coagulation testing but need periodic kidney function, liver function, and complete blood counts because dosing depends on renal clearance and any drop in hemoglobin needs explanation. Drug-interaction review is repeated at every visit and any time a new medication or supplement is added. Same-day office labs and direct access mean that bleeding concerns, periprocedural questions, or new symptoms reach Dr. Kedan promptly rather than waiting for the next appointment.

How Cardiolucent Manages This

Anticoagulation done well requires more than a prescription — it requires a physician who is reachable when a procedure is scheduled, when an unexpected bleed happens, or when a new medication threatens to upend the regimen. Dr. Kedan provides extended visits for shared decision-making about agent selection and duration, coordinates periprocedural management directly with surgeons and proceduralists, and integrates the anticoagulation plan with the overall cardiovascular program. The concierge model removes the friction that causes most anticoagulation errors to happen at handoffs.

Common Questions

Frequently Asked Questions

Why do I need anticoagulation in the first place?
Anticoagulants are prescribed when your risk of forming a clot — and suffering a stroke or other thromboembolic event — outweighs the bleeding risk of being on the medication. The most common indications are atrial fibrillation, mechanical heart valves, prior deep vein thrombosis or pulmonary embolism, and certain hypercoagulable conditions. Dr. Kedan uses validated tools like CHA2DS2-VASc and HAS-BLED to quantify both sides of that equation before starting therapy and to revisit it over time.
How does Dr. Kedan choose between a DOAC and warfarin?
For most patients with non-valvular atrial fibrillation, a direct oral anticoagulant (apixaban, rivaroxaban, dabigatran, or edoxaban) is preferred because of more predictable dosing, fewer dietary interactions, and no routine blood monitoring. Warfarin remains the right choice in specific situations — mechanical heart valves, certain valvular conditions, severe kidney impairment, or when a DOAC is not tolerated. The decision is individualized to your anatomy, kidney function, other medications, and lifestyle.
How long will I need to be on anticoagulation?
For atrial fibrillation, mechanical valves, and recurrent thromboembolism, anticoagulation is typically lifelong because the underlying risk does not resolve. For a single provoked clot — say, after surgery or immobility — three to six months may be sufficient. Dr. Kedan revisits the duration question at every reassessment, especially if your bleeding risk profile changes.
What bleeding signs should I take seriously?
Call promptly for any bleeding that does not stop with pressure, blood in the urine or stool (including black, tarry stools), coughing or vomiting blood, severe or unusual headache, vision changes, or any significant trauma — particularly head trauma. Easy bruising and minor nosebleeds are common and usually not dangerous, but worsening patterns are worth a conversation. Direct access to Dr. Kedan means you do not have to guess whether something warrants an ER visit.
Do I need blood tests while on anticoagulation?
Warfarin requires regular INR monitoring to keep you in the therapeutic range. DOACs do not require routine coagulation monitoring, but periodic kidney function, liver function, and complete blood counts are checked because dosing depends on renal clearance and any drop in hemoglobin needs investigation. The lab cadence is set per medication and per patient.
What about anticoagulation when I need surgery or a procedure?
Periprocedural management is one of the most important and most mishandled parts of anticoagulation. Dr. Kedan coordinates directly with your surgeon or proceduralist to determine when to hold the anticoagulant, whether bridging with a short-acting agent is needed, and exactly when to resume — balancing the risk of clot against the risk of bleeding at the surgical site. Always notify Dr. Kedan as soon as a procedure is scheduled, not the day before.
Which medications and supplements interact with anticoagulants?
Many — and the interactions matter. NSAIDs (ibuprofen, naproxen) sharply increase bleeding risk and should generally be avoided. Certain antibiotics, antifungals, antiarrhythmics, and seizure medications can raise or lower DOAC levels significantly. Supplements like fish oil, ginkgo, garlic, and turmeric add to bleeding risk; St. John's wort reduces DOAC effectiveness. Bring a complete list of everything you take — including over-the-counter products — to every visit.
Can I drink alcohol while on a blood thinner?
Light, occasional alcohol is generally acceptable for most patients on a DOAC, but heavy or binge drinking increases both bleeding risk and the chance of falls. For patients on warfarin, alcohol can directly affect INR stability, so consistency matters more than abstinence. Dr. Kedan will give you a specific answer based on your medication, liver function, and overall risk profile.
What if I miss a dose?
The rule depends on which anticoagulant you take and how late you are. For most DOACs taken once daily, take the missed dose as soon as you remember the same day; if you do not remember until the next day, skip it — do not double up. For twice-daily regimens the window is shorter. Warfarin has its own rules. Keep written instructions for your specific medication, and call if you are unsure rather than guessing.
How does cost and insurance work for anticoagulation care?
Cardiolucent does not accept Medicare or insurance and bills patients directly for office visits and management; the medications themselves are billed through your pharmacy benefit as usual. We provide detailed superbills you can submit to your carrier for out-of-network reimbursement. If cost of a specific DOAC is a barrier, Dr. Kedan will discuss alternatives and patient assistance programs — schedule a consultation to map out the right regimen for your situation.

Explore

Related Treatments

Ready to learn more about Anticoagulation Management?

Schedule a private consultation with Dr. Kedan in Beverly Hills.
Schedule an Appointment

Medical Disclaimer

The information on this site is for general educational purposes only and is not medical advice, diagnosis, or treatment. Reading this site does not create a doctor–patient relationship. Always consult a qualified healthcare professional for personal guidance. If this is an emergency, call 911. Mentions of medications, devices, or procedures are informational and not endorsements. Full medical disclaimer.

†Some listed indications involve investigational/off-label use. Learn more.